# Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia

> **NCT01117454** · NA · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 14 (actual)

## Conditions studied

- Catecholaminergic Polymorphic Ventricular Tachycardia

## Interventions

- **DRUG:** Flecainide Acetate
- **DRUG:** Placebo
- **DRUG:** Beta blocker

## Key facts

- **NCT ID:** NCT01117454
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2017-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01117454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01117454, "Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01117454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*